Relief Therapeutics Correlations

RLFFDDelisted Stock   3.13  0.13  4.33%   
The current 90-days correlation between Relief Therapeutics and Boston Omaha Corp is -0.02 (i.e., Good diversification). The correlation of Relief Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Relief Therapeutics Correlation With Market

Good diversification

The correlation between Relief Therapeutics Holding and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Relief Therapeutics Holding and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Relief Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Relief Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Relief Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Relief Therapeutics Holding to buy it.

Moving against Relief OTC Stock

  0.7TD Toronto Dominion Bank Earnings Call This WeekPairCorr
  0.61OILCF Permex Petroleum TrendingPairCorr
  0.31BRK-B Berkshire HathawayPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SUMGLBE
STGWVMC
VMCBOC
GLBEMCHX
SUMMCHX
STGWBOC
  
High negative correlations   
FLNTGLBE
SUMFLNT
FLNTMCHX
GLBEBOC
SUMBOC
MCHXBOC

Risk-Adjusted Indicators

There is a big difference between Relief OTC Stock performing well and Relief Therapeutics OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Relief Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Relief Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Relief Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Relief Therapeutics could also be used in its relative valuation, which is a method of valuing Relief Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Still Interested in Relief Therapeutics Holding?

Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.